SEngine Precision Medicine CEO and leadership

Carla Grandori is a Chief Executive Officer at SEngine Precision Medicine Inc, Scientific Director at Cure First, and Founder and President at Cure First and is based in Seattle, Washington. She has worked as Research Member at Fred Hutch; Research Fellow at MERCK & CO., INC.; and Post-Doctoral Fellow at MIT. Carla studied at University of Rome, Medical School, Italy between 1976 and 1982 and Rockefeller University between 1984 and 1989.

20 years of consistent achievement and advancement with broad executive management skills. Extensive experience in business development and pre-clinical and clinical operations. Strengths include strategic planning, budgeting, and managing of business operations. Experience was gained in both not-for-profit and for-profit organizations.

Chief Medical Officer of a SEngine Precision Medicine biotech, for developing US product portfolio strategy and clinical validation of the cancer prediction PARIS cancer test , using tumor organoids to test oncological drugs sensitivity.Longstanding experience as breast cancer surgeon, clinical trials researcher and biobank strategic planning expert, as well as operation of breast cancer care center, including its research biobanking facilities. Ability to bring in-depth knowledge of key issues and opportunities into breast cancer research, biospecimen application, biotechnologies, software development or management project. She worked for Myriad Genetics as part of advisory board and scientific speaker for a breast cancer prediction RNA based test Endopredict since 2013 to 2020. Previously , she worked as Scientific advisor and Speaker for Latin America and Argentina for Oncotype ( Genomic Health USA) and for Mamma print ( Agendia) .Breast Surgeon, Principal Investigator focused in Breast Cancer. Extended experience in regulatory affairs for clinical trials in LA TAM and USA, new drugs and epigenetics bio markers development in breast cancer, bio banks and bio specimen strategies .Proprietary Cancer Biobank Management Software creator.

CFO/COO/CPA with deep international Financial and Operations background. Specialties: Biotech, Computer software (SAAS), Satellites, Intellectual Property, Online Consumer Subscription, CFO consulting, COO Consulting, Construction Rental and Sales

Carla Grandori is a Chief Executive Officer at SEngine Precision Medicine Inc, Scientific Director at Cure First, and Founder and President at Cure First and is based in Seattle, Washington. She has worked as Research Member at Fred Hutch; Research Fellow at MERCK & CO., INC.; and Post-Doctoral Fellow at MIT. Carla studied at University of Rome, Medical School, Italy between 1976 and 1982 and Rockefeller University between 1984 and 1989.